BMC health services research · 2025
Co-design of a multifaceted intervention to improve quality handover of medicine information at discharge from hospital.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Hattingh H Laetitia, Percival Matt, Johnston Kate, Tobiano Georgia, Hirsch Hayley, de Wet Carl, Memon Salim, Morgan Mark A, Raleigh Rachael, Baglot Noela, Gillespie Brigid M
Аннотация
BACKGROUND: Timely and accurate discharge medicine information is essential for primary care clinicians, including general practitioners and community pharmacists, to provide safe and effective post-discharge care. Inadequate handover of discharge medicines poses risks of medication-related harm, compromising patient safety and leads to hospital readmissions. This study aimed to develop a multifaceted intervention targeting older patients (>65 years) to enhance medicine handover at hospital discharge.
METHODS: Following an initial consensus-building workshop, a structured five-step co-design process was implemented. Step 1 involved workshops and interviews with hospital clinicians, hospital leadership, primary care providers, and consumers experienced in discharge medicine handover. Stakeholder input in Step 2 refined intervention components and developed training materials. Step 3 obtained endorsement from health service decision makers and governance approvals. Step 4 included pharmacist upskilling, end-user testing, and feedback collection. Step 5 finalised intervention components and constructed a Logic Model.
RESULTS: Seventy-eight stakeholders participated in workshops and interviews from August to November 2023. Four key medicine handover objectives for older patients emerged, which were operationalised into intervention recommendations over a five-month period (December 2023-April 2024). Component 1 empowered patients to query clinicians about their medications via a dedicated website with a question builder and evidence-based resources. Component 2 involved training doctors to document reasons for medicine changes in patient records. Component 3 implemented patient risk stratification to guide tailored strategies for communication to primary care clinicians. Component 4 focused on discharge reconciliation planning by unit pharmacists in collaboration with physicians. End-user testing yielded positive feedback.
CONCLUSIONS: A co-designed multifaceted intervention was developed to enhance medicine handover during hospital discharge. The intervention will undergo feasibility testing to assess its impact on reducing medication-related harm and hospital readmissions.
METHODS: Following an initial consensus-building workshop, a structured five-step co-design process was implemented. Step 1 involved workshops and interviews with hospital clinicians, hospital leadership, primary care providers, and consumers experienced in discharge medicine handover. Stakeholder input in Step 2 refined intervention components and developed training materials. Step 3 obtained endorsement from health service decision makers and governance approvals. Step 4 included pharmacist upskilling, end-user testing, and feedback collection. Step 5 finalised intervention components and constructed a Logic Model.
RESULTS: Seventy-eight stakeholders participated in workshops and interviews from August to November 2023. Four key medicine handover objectives for older patients emerged, which were operationalised into intervention recommendations over a five-month period (December 2023-April 2024). Component 1 empowered patients to query clinicians about their medications via a dedicated website with a question builder and evidence-based resources. Component 2 involved training doctors to document reasons for medicine changes in patient records. Component 3 implemented patient risk stratification to guide tailored strategies for communication to primary care clinicians. Component 4 focused on discharge reconciliation planning by unit pharmacists in collaboration with physicians. End-user testing yielded positive feedback.
CONCLUSIONS: A co-designed multifaceted intervention was developed to enhance medicine handover during hospital discharge. The intervention will undergo feasibility testing to assess its impact on reducing medication-related harm and hospital readmissions.